Placebo News and Research

RSS

Diabetes drug reduces cardiovascular events and kidney problems, study finds

A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes.

10 Jun 2019

FDA authorizes marketing of first medical device for pain relief in adolescents with IBS

The U.S. Food and Drug Administration today permitted marketing of the first medical device to aid in the reduction of functional abdominal pain in patients 11-18 years of age with irritable bowel syndrome when combined with other therapies for IBS.

10 Jun 2019

No lasting improvement in insulin secretion with diabetic medication

Adults with type 2 diabetes mellitus respond to medical treatment by producing more insulin, but there is no long-term effect on insulin secretion after treatment stops, concluded a pair of clinical trials.

9 Jun 2019

Vitamin D supplement does not prevent type 2 diabetes in adults at high risk, study finds

Taking a daily vitamin D supplement does not prevent type 2 diabetes in adults at high risk, according to results from a study funded by National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health.

8 Jun 2019

New research provides welcomed news for countless patients taking PPIs

For patients taking proton pump inhibitors to treat gastroesophageal disease (GERD) or other acid-related conditions, new research puts safety concerns to rest.

7 Jun 2019

Three-drug combination could be effective therapy for people with advanced melanoma

A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma.

7 Jun 2019

Still-to-be-approved drug proves to be new option for treating active rheumatoid arthritis

In a large-scale, international study led by renowned rheumatologist Josef Smolen from the Department of Medicine III, a still-to-be-approved drug containing the selective janus kinase inhibitor upadacitinib has proved itself to be a new option for treating active rheumatoid arthritis.

7 Jun 2019

Alzheimer's therapy may be effective in treating individuals addicted to opioids

Clinical trial results reveal that a medication used to treat Alzheimer's disease may also be an effective therapy for individuals addicted to opioids. The findings are published in The American Journal on Addictions.

6 Jun 2019

FDA approves first vaccine for prevention of dengue disease in endemic regions

The U.S. Food and Drug Administration announced today the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages 9 through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas.

6 Jun 2019

Vitamin D could extend lifespan of cancer patients

Michigan State University physicians have found that vitamin D, if taken for at least three years, could help cancer patients live longer.

4 Jun 2019

Targeted breast cancer therapy shows 'encouraging' results

Researchers have developed a targeted therapy that may significantly increase the survival of pre-menopausal women with advanced breast cancer

3 Jun 2019

Georgetown University Medical Center announces launch of clinical trial for Lewy body dementia

Georgetown University Medical Center announces the launch of the only known therapeutic (disease modifying) clinical trial for Lewy body dementia, a neurological disorder that affects a million people in the United States for which there are no approved medications that modify the disease.

3 Jun 2019

Targeted therapy plus hormone therapy improves survival in premenopausal patients with advanced HR+ breast cancer

Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in premenopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

3 Jun 2019

Eating blueberries daily reduces the risk of cardiovascular disease

Eating a cup of blueberries a day reduces risk factors for cardiovascular disease - according to new research led by the University of East Anglia, in collaboration with colleagues from Harvard and across the UK.

31 May 2019

Energy drinks may increase blood pressure and risk of electrical disturbances in heart

Drinking 32 ounces of an energy drink in a short timespan may increase blood pressure and the risk of electrical disturbances in the heart, which affect heart rhythm, according to a small study published in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.

29 May 2019

Placebo News and Research

Diabetes drug reduces cardiovascular events and kidney problems, study finds

FDA authorizes marketing of first medical device for pain relief in adolescents with IBS

No lasting improvement in insulin secretion with diabetic medication

Vitamin D supplement does not prevent type 2 diabetes in adults at high risk, study finds

New research provides welcomed news for countless patients taking PPIs

Three-drug combination could be effective therapy for people with advanced melanoma

Still-to-be-approved drug proves to be new option for treating active rheumatoid arthritis

Alzheimer's therapy may be effective in treating individuals addicted to opioids

FDA approves first vaccine for prevention of dengue disease in endemic regions

Vitamin D could extend lifespan of cancer patients

Targeted breast cancer therapy shows 'encouraging' results

Georgetown University Medical Center announces launch of clinical trial for Lewy body dementia

Targeted therapy plus hormone therapy improves survival in premenopausal patients with advanced HR+ breast cancer

Eating blueberries daily reduces the risk of cardiovascular disease

Energy drinks may increase blood pressure and risk of electrical disturbances in heart

Epigenetic research provides new approaches to cancer combination therapies

Drug therapy for stable heart failure patients can be simplified by stopping diuretics

Short-term opioid use increases the positivity of emotional experiences

Skin patch may be useful in treating children with milk-induced EoE

New opioid accelerates recovery and prevents relapse to chronic pain

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News